4//SEC Filing
Cara Therapeutics, Inc. 4
Accession 0001209191-17-019916
$TVRDCIK 0001346830operating
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 5:21 PM ET
Size
5.6 KB
Accession
0001209191-17-019916
Insider Transaction Report
Form 4
Lewis Michael E
Chief Scientific Advisor
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-03-08+20,000→ 20,000 totalExercise: $17.41Exp: 2027-03-08→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 8, 2017, in each case subject to the reporting person's Continuous Service (as defined in the 2014 Equity Incentive Plan) as of each such date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001346830
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 5:21 PM ET
- Size
- 5.6 KB